Bronchiectasis: Clinical Trials

3 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients
ALX-009, OSCN-, bLF - Cystic Fibrosis, Bronchiectasis
Phase 1TerminatedAlaxia SAS922015-11-012022-02-03
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
GSK2793660 solution, GSK2793660 capsule, Placebo solution - Bronchiectasis
Phase 1TerminatedGlaxoSmithKline332014-01-282018-09-13
Study of the Effect of FLUTTERĀ® VRP1 (PEP and Oscillating High Frequency).
control group, Flutter group, PEP group - Bronchiectasis
Phase 1TerminatedUniversity of Sao Paulo302007-07-012012-06-28

Narrower conditions

Cystic Fibrosis (1)

Broader conditions

Bronchial Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Infant, Newborn, Diseases (1)  ·  Lung Diseases (1)  ·  Pancreatic Diseases (1)

Interventions

Control Groups (1)  ·  GSK-2793660 (1)  ·  Population Groups (1)  ·  Therapeutics (1)  ·  hypothiocyanite ion (1)

Sponsors

Alaxia SAS (1)  ·  GlaxoSmithKline (1)  ·  University of Sao Paulo (1)

Countries

Brazil (1)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Ada C. Gastaldi, doctor (1)  ·  Isabelle Durieu, Prof., MD (1)

Results publications

PMID 11978924, PMID 1280928, PMID 28733314, PMID 28800383, PMID 9674466

NIH funding

2014 (1)